Jul 17, 2025 12:04PM Needham Downgrades Clearside Biomedical (CLSD) to Hold

Jul 17, 2025 09:07AM Jones Trading Downgrades Clearside Biomedical (CLSD) to Hold

Jul 17, 2025 07:05AM Clearside Biomedical explores strategic alternatives for eye drug platform

May 27, 2025 06:38AM Clearside Biomedical (CLSD) PT Lowered to $5 at H.C. Wainwright

May 16, 2025 04:03AM Citizens JMP Reiterates Market Outperform Rating on Clearside Biomedical (CLSD)

May 15, 2025 10:01AM Stifel Reiterates Buy Rating on Clearside Biomedical (CLSD)

May 14, 2025 04:29PM Clearside Biomedical (CLSD) Misses Q1 EPS by 2c

Apr 23, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on Clearside Biomedical (CLSD)

Mar 28, 2025 07:30AM Stifel Reiterates Buy Rating on Clearside Biomedical (CLSD)

Mar 28, 2025 04:41AM Citizens JMP Reiterates Market Outperform Rating on Clearside Biomedical (CLSD)

Mar 27, 2025 04:18PM Clearside Biomedical (CLSD) Reports In-Line Q4 EPS

Mar 6, 2025 07:06AM Clearside Biomedical (CLSD) Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD

Feb 20, 2025 07:06AM Clearside Biomedical (CLSD) Announced Acceptance of its New Drug Application for ARCATUS for Regulatory Review in China for the Treatment of Uveitic Macular Edema

Feb 10, 2025 07:05AM Clearside Biomedical (CLSD) Reports Additional Data from the CLS-AX ODYSSEY Phase 2b Trial

Jan 22, 2025 07:05AM Clearside Biomedical (CLSD) Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and Singapore

Dec 19, 2024 07:07AM Clearside Biomedical (CLSD) Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye

Nov 25, 2024 07:05AM Clearside Biomedical (CLSD) Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States

Nov 12, 2024 04:11PM Clearside Biomedical (CLSD) Tops Q3 EPS by 2c

Nov 7, 2024 09:05AM Clearside Biomedical (CLSD) Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment o

Nov 4, 2024 07:06AM Clearside Biomedical (CLSD) Appoints Tony Gibney as Board Chair

Oct 22, 2024 07:05AM Clearside Biomedical's (CLSD) Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting

Oct 9, 2024 06:30AM Clearside Biomedical (CLSD) Reports Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX

Aug 28, 2024 06:48AM H.C. Wainwright Reiterates Buy Rating on Clearside Biomedical (CLSD)

Aug 27, 2024 11:11AM Jones Trading Reiterates Buy Rating on Clearside Biomedical (CLSD)

Aug 21, 2024 05:36AM Chardan Capital Markets Starts Clearside Biomedical (CLSD) at Buy

Aug 12, 2024 04:36PM Clearside Biomedical (CLSD) Tops Q2 EPS by 3c

Jul 11, 2024 07:07AM Clearside Biomedical (CLSD) Appoints Glenn Yiu to its Scientific Advisory Board